List of largest biotechnology and pharmaceutical companies

The following is a list of the independent biotechnology companies listed on a stock exchange (as indicated) with current market capitalization of at least USD 10 billion, in decreasing order.

The list does not include biotechnology companies that are currently owned by, or a part of, larger pharmaceutical groups.

Rankings

Rank[N 1] Company Largest Market Cap (USD billions) Market Cap in 2019 (USD billions) Market Cap in 2018 (USD billions) Market Cap in 2017 (USD billions) Market Cap in 2016 (USD billions)[1][2] Market Cap in 2015 (USD billions)[3] Market Cap in 2014 (USD billions)[4] Market Cap in 2013 (USD billions)
1 Johnson & Johnson[P]
NYSE: JNJ
397.4 (Jan 2018) 385.0 346.1 375.4 314.1 284.2 277.8 258.3
2 1 Roche[P]
SIX: ROG
263.6 (Dec 2019) 281.1 209.3 216.7 192.1 234.7 258.5 240.3
3 2 Novartis[P]
NYSE: NVS
275.2 (Jul 2015) 240.0 200.0 196.7 170.5 206.1 229.8 195.0
4 Merck & Co.[P]
NYSE: MRK
232.9 (Dec 2019) 232.9 205.8 153.3 164.3 147.6 166.9 146.5
5 3 Pfizer[P]
NYSE: PFE
310.5 (Jul 2000) 216.7 259.7 215.9 196.3 199.3 205.4 196.0
6 2 Abbott Laboratories[P]
NYSE: ABT
153.5 (Dec 2019) 153.5 126.8 99.3 56.4 67.0 67.9 59.3
7 Amgen[B]
NASDAQ: AMGN
145.8 (Dec 2019) 144.6 128.8 126.2 108.9 122.5 93.1 78.7
8 2 Novo Nordisk[P]
NYSE: NVO
159.6 (Aug 2015) 137.1 111.9 131.2 92.6 153.9 125.4 19.6
9 3 AbbVie[P]
NYSE: ABBV
196.2 (Jan 2018) 130.9 146.3 154.4 100.2 96.8 104.1 83.8
10 2 AstraZeneca[P]
NYSE: AZN
130.8 (Dec 2019) 130.8 96.2 87.9 68.8 85.8 88.9 74.6
11 2 Eli Lilly & Co[P]
NYSE: LLY
131.2 (Feb 2019) 126.9 125.6 93.0 80.9 93.4 76.6 57.0
12 1 GlaxoSmithKline[P]
NYSE: GSK
174.9 (May 2006) 117.2 94.8 87.9 93.3 97.6 128.9 129.6
13 1 Bristol-Myers Squibb[P]
NASDAQ: BMY
128.3 (Jul 2016) 105.0 85.0 100.3 98.2 114.8 97.6 87.2
14 1 Gilead Sciences[B]
NASDAQ: GILD
179.6 (Jun 2013) 82.3 81.6 93.6 96.6 145.8 109.0 78.4
15 2 Bayer[B]
FWB: BAYN
129.0 (Mar 2015) 80.1 63.1 101.9 85.3 103.2 113.2 117.4
16 2 Stryker Corporation[P]
NYSE: SYK
67.6 (Feb 2019) 78.5 58.6 58.0 45.1 34.7 35.7 28.4
17 6 Sanofi[P]
NYSE: SNY
151.3 (Sep 2014) 63.5 108.4 108.2 101.8 111.8 138.1 142.0
18 7 Zoetis[P]
NASDAQ: ZTS
63.2 (Dec 2019) 63.2 41.4 35.1 26.4 23.8 21.6 16.3
19 3 Allergan[P]
NYSE: AGN
133.5 (Jul 2015) 62.7 46.2 54.4 72.7 123.3 68.5 29.3
20 Takeda Pharmaceutical [P]
NASDAQ: TYO
61.5 (Dec 2019) 61.5 52.9 40.2 45.6 47.8 37.5 34.3
21 3 Vertex Pharmaceuticals[P]
NASDAQ: VRTX
56.3 (Dec 2019) 56.3 42.2 37.9 18.3 31.0 28.7 17.4
22 6 Biogen[B]
NASDAQ: BIIB
111.7 (Mar 2015) 54.7 63.5 67.4 61.6 68.3 79.7 66.1
23 Illumina [B]
NASDAQ: ILMN
56.0 (Jul 2019) 48.2 44.1 40.2 39.4 35.4 28.6 25.7
24 2 Regeneron Pharmaceuticals[P]
NASDAQ: REGN
61.4 (Aug 2015) 41.2 40.3 40.4 39.3 56.5 42.0 27.4
25 2 Astellas[P]
TYO: 4503
35.9 (Nov 2017) 32.7 23.8 29.3 25.7 40.6 35.8 27.6
26 3 Daiichi Sankyo [P]
NASDAQ: DSNKY
45.3 (Dec 2019) 45.3 22.7 27.5 35.3 38.8 33.2 28.7
27 3 Alexion Pharmaceuticals[P]
NASDAQ: ALXN
47.0 (Jul 2015) 24.3 21.7 26.7 27.4 43.1 36.7 26.0
28 Eisai Pharmaceutical [P]
TYO: 4523
24.7 (June 2018) 21.5 23.0 24.5 37.3 28.8 30.2 28.7
29 4 Incyte [P]
NASDAQ: INCY
31.2 (Mar 2017) 18.8 13.5 18.3 15.4 10.6 7.3 4.6
30 1 BioMarin [P]
NASDAQ: BMRN
24.0 (Jul 2015) 15.2 15.1 18.3 20.4 13.8 12.9 10.8
31 1 Mylan [P]
NASDAQ: MYL
37.2 (Apr 2015) 10.4 14.1 27.5 30.3 38.8 33.2 35.7
32 2 Perrigo [P]
NASDAQ: PRGO
29.0 (May 2017) 7.0 5.5 9.9 9.5 8.3 14.7 12.2
33 2 United Therapeutics [P]
NASDAQ: UTHR
6.0 (May 2018) 3.9 5.5 8.9 7.5 8.3 11.7 7.2
34 2 Bausch Health [P]
8.0 (May 2018) 9.9 5.5 8.9 6.5 4.3 11.7 8.2

Footnotes

  1. The change is the companies' relative position in this list, compared to their relative position in the prior year; i.e, an increase would be moving closer to rank 1 and vice versa
  • B – Biotechnology company
  • P – Pharmaceutical company

See also

  • List of largest pharmaceutical companies by revenue

References

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.